8.50-0.45-4.97%
Official Close 05:20:00 PM EDT 6/14/2024NASO
Plus500. 81% of retail CFD accounts lose money
| News | Analyst Data | Analyst Opinions | Insider Activity | Dividend Calendar |
New: Online Broker Comparison!Learn more about the best online brokers in our new comparison! Find out more!
Trulieve Cannabis Stock Snapshot
159.76 M
Number of Shares
0.00
Dividend in USD
0.00
Dividend Yield
94.59
Free Float in %
-3.76
EPS in USD
10.01
Book Value per Share in USD
1.44
Cash Flow per Share in USD
Trulieve Cannabis NewsMore News
TipRanks
Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (OtherTCNNF) and Annexon Biosciences (ANNX)
InvestorPlace
The 3 Most Undervalued Cannabis Stocks to Buy in June 2024
Benzinga
TDR Research Rates Trulieve Cannabis A 'Buy', Potential 46% Stock Price Upside
TDR Research has recently initiated coverage of multi-state cannabis company Trulieve (OTC: TCNNF), assigning it a “Buy” rating based on an extensive analysis of the company's financial health and growth potential.
Trulieve Cannabis Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 05/10/24 | Needham & Company, LLC | Maintained Buy | $14.5 | gut | ||
| 03/05/24 | Seaport Global Securities | Maintained Buy | $16 | gut | ||
| 03/01/24 | Needham & Company, LLC | Maintained Buy | $13.5 | gut | ||
| 11/09/23 | Needham & Company, LLC | Maintained Buy | $6.5 | gut | ||
| 08/11/23 | Wedbush Morgan Securities Inc. | Maintained Buy | $6 | gut | ||
| 08/10/23 | Needham & Company, LLC | Maintained Buy | $9 | gut | ||
| 05/10/23 | Needham & Company, LLC | Maintained Buy | $10 | gut | ||
| 03/09/23 | Needham & Company, LLC | Maintained Buy | $12 | gut | ||
| 03/09/23 | Cantor Fitzgerald | Maintained Buy | $37 | gut | ||
| 03/06/23 | Cantor Fitzgerald | Maintained Buy | $41 | gut | ||
| 12/02/22 | Wedbush Morgan Securities Inc. | Maintained Buy | $18 | gut | ||
| 11/10/22 | Cantor Fitzgerald | Maintained Buy | $51 | gut | ||
| 08/11/22 | Cantor Fitzgerald | Maintained Buy | $54 | gut | ||
| 07/22/22 | Seaport Global Securities | Maintained Buy | $23 | gut |
Trulieve Cannabis Estimates* in USD
| 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|
| Revenue | 1,182 | 1,245 | 1,220 | 1,455 | 1,579 |
| Dividend | 0.00 | 0.00 | - | - | - |
| Dividend Yield (in %) | 0.00 % | 0.00 % | - | - | - |
| EPS | -0.38 | -0.18 | 0.18 | -0.11 | -0.07 |
| P/E Ratio | -22.12 | -48.50 | 47.22 | -77.27 | -121.43 |
| EBIT | 176 | 192 | 205 | 240 | - |
| EBITDA | 374 | 383 | 381 | 432 | 466 |
| Net Profit | -74 | -27 | 88 | -17 | - |
| Net Profit Adjusted | -100 | -76 | -59 | - | - |
| Pre-Tax Profit | 114 | 148 | 197 | 155 | - |
| Net Profit (Adjusted) | - | - | - | - | - |
| EPS (Non-GAAP) ex. SOE | -0.37 | -0.13 | 0.39 | - | - |
| EPS (GAAP) | -0.42 | 0.02 | 0.86 | - | - |
| Gross Income | 667 | 683 | 587 | 815 | - |
| Cash Flow from Investing | -71 | -50 | -25 | -74 | - |
| Cash Flow from Operations | 273 | 238 | 181 | 139 | - |
| Cash Flow from Financing | -12 | 6 | -15 | -17 | - |
| Cash Flow per Share | 0.99 | 1.02 | - | - | - |
| Free Cash Flow | 199 | 185 | 156 | 96 | - |
| Free Cash Flow per Share | 1.37 | 1.21 | 0.39 | - | - |
| Book Value per Share | 6.90 | 7.18 | 7.16 | - | - |
| Net Debt | 170 | -145 | -574 | 97 | - |
| Research & Development Exp. | - | - | - | - | - |
| Capital Expenditure | 69 | 44 | 25 | 36 | - |
| Selling, General & Admin. Exp. | 433 | 448 | 366 | - | - |
| Shareholder’s Equity | 1,326 | 1,270 | 1,369 | 1,382 | - |
| Total Assets | 2,837 | 2,885 | 2,854 | 2,772 | - |
| Previous Quarter ending 03/31/24 | Current Quarter ending 06/30/24 | Next Quarter ending 09/30/24 | Current Year ending 12/31/24 | Next Year ending 12/31/25 | |
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | 9 | 7 | 7 | 11 | 11 |
| Average Estimate | -0.102 USD | -0.087 USD | -0.090 USD | -0.384 USD | -0.175 USD |
| Year Ago | -0.340 USD | -2.140 USD | -0.130 USD | -2.790 USD | -0.384 USD |
| Publish Date | 5/9/2024 | 8/7/2024 | 11/7/2024 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | 15 | 13 | 13 | 14 | 13 |
| Average Estimate | 285 USD | 293 USD | 293 USD | 1,182 USD | 1,245 USD |
| Year Ago | 289 USD | 282 USD | 275 USD | 1,129 USD | 1,182 USD |
| Publish Date | 5/9/2024 | 8/7/2024 | 11/7/2024 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales | 1,524.06 | 1,614.05 | 1,176.48 | 699.53 | 335.46 | 133.27 | 25.67 |
| Change of sales in % | -5.58 | 37.19 | 68.18 | 108.53 | 151.73 | 419.10 | 11,924.33 |
| Gross profit on sales | 646.23 | 732.45 | 649.48 | 501.40 | 26.01 | 24.45 | 11.01 |
| Gross profit on sales change in % | -11.77 | 12.78 | 29.53 | 1,827.69 | 6.39 | 121.95 | - |
| Operating income | 125.04 | 140.54 | 253.65 | 292.89 | -63.87 | -13.38 | 0.23 |
| Operating income change in % | -11.03 | -44.59 | -13.40 | - | -377.25 | - | - |
| Income before tax | -384.04 | -56.43 | 204.99 | 211.19 | 361.54 | 92.97 | 10.76 |
| Income before tax change in % | -580.57 | - | -2.93 | -41.59 | 288.88 | 763.89 | - |
| Income after tax | -711.01 | -320.34 | 22.61 | 84.50 | 236.23 | 55.69 | 4.64 |
| Income after tax change in % | -121.96 | - | -73.25 | -64.23 | 324.17 | 1,100.89 | - |
Balance Sheet in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 1,801.58 | 2,116.14 | 1,641.31 | 479.60 | 401.74 | 79.79 | 28.50 |
| Long-term liabilities per share | 8.86 | 9.85 | 7.91 | 3.20 | 2.97 | 0.29 | 0.17 |
| Equity | 1,857.40 | 2,611.94 | 2,712.45 | 570.63 | 366.15 | 142.34 | 13.94 |
| Equity change in % | -28.72 | -3.46 | 375.00 | 55.85 | 157.23 | 921.47 | - |
| Balance sheet total | 3,658.98 | 4,728.08 | 4,353.76 | 1,050.23 | 767.88 | 222.14 | 42.44 |
| Balance sheet total change in % | -22.61 | 8.60 | 314.55 | 36.77 | 245.68 | 423.45 | 326.64 |
Key Data in USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 8.06 | 8.59 | 8.02 | 5.91 | 2.91 | 1.31 | 0.23 |
| P/E ratio (year end quote, basic EPS) | - | - | 202.90 | 54.03 | 7.17 | 20.09 | - |
| P/E ratio (ear end quote, diluted EPS) | - | - | 213.70 | 56.29 | 7.50 | 20.13 | - |
| P/E ratio (year end quote) | - | - | 202.90 | 54.03 | 7.17 | 20.09 | - |
| Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Equity ratio in % | 50.97 | 55.34 | 62.26 | 54.33 | 47.68 | 64.08 | 32.84 |
| Debt ratio in % | 49.24 | 44.76 | 37.70 | 45.67 | 52.32 | 35.92 | 67.16 |
Trulieve Cannabis Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2022 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2021 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2020 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2019 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2018 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | 0.00 | 0.00 | USD |
| 2017 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | - | - | USD |
| 2016 | Trulieve Cannabis Corp Registered Shs Subordinate Voting | - | - | USD |
*Yield of the Respective Date
Trulieve Cannabis Corp Registered Shs Subordinate Voting Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | -0.087 USD | Q2 2024 Earnings Release | 08/07/2024 |
| Earnings Report | -0.090 USD | Q3 2024 Earnings Release | 11/07/2024 |
| Earnings Report | - | Q4 2024 Earnings Release | 03/26/2025 |
| Earnings Report | - | Q1 2025 Earnings Release | 05/08/2025 |
Trulieve Cannabis Corp Registered Shs Subordinate Voting Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Annual General Meeting | - | Annual General Meeting | 06/12/2024 |
| Press Conference | - | - | 05/09/2024 |
| Earnings Report | -0.120 USD | Q1 2024 Earnings Release | 05/09/2024 |
| Press Conference | - | - | 02/29/2024 |
| Press Conference | - | - | 11/09/2023 |
| Press Conference | - | - | 08/09/2023 |
Trulieve Cannabis Profile
Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Tallahassee, FL.
Trulieve Cannabis Shareholder
| Owner | in % |
|---|---|
| Freefloat | 94.59 |
| Nomura Securities International, Inc. (Invt Mgmt) | 7.29 |
| Thad Beshears | 3.40 |
| Kimberly A. Rivers | 1.24 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
